GLP-1 receptor agonist use does not increase insulin discontinuation with type 2 diabetes

Medical Xpress

For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other glucose-lowering agents, according to a study published online July 14 in the Annals of Internal Medicine. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

GLP-1 receptor agonist use does not increase insulin discontinuation with type 2 diabetes

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Study finds mixed associations between breastfeeding and childhood allergies

For older women, water offers more than just physical health benefits

Researchers discover rare freshwater mussels in Moosup River

Medical Xpress의 다른 기사

Endometriosis presents symptom patterns that go beyond pain

Disrupted antioxidant balance linked to the development of 'Skellefteå disease'

Impact of overweight on cancer risk may be significantly underestimated